Gerresheimer AG's management has firmly shut the door on a lucrative takeover offer, choosing instead to navigate a complex corporate restructuring alone. The Düsseldorf-based packaging specialist rejected an unsolicited bid from US rival Silgan Holdings Inc., which had proposed paying €41 per share. This price represented a near 100% premium to the trading level at the time, a premium shareholders will now forgo as the company focuses on selling assets and resolving accounting issues.

The decision has widened the rift between the board and its investors. The stock, trading around €21.00, has shed roughly 24% since the start of the year and now sits nearly 60% below its level from twelve months ago. Shareholders view the spurned bid as a missed opportunity to crystallize value, leaving them exposed to the company's ongoing operational and regulatory risks.

Central to Gerresheimer's standalone strategy is the urgent sale of its US subsidiary, Centor. Acquired roughly a decade ago for $725 million, the profitable plastic packaging unit is now seen as the key to reducing debt. More than ten potential buyers have already expressed interest, providing the management team with crucial negotiating leverage. CFO Wolf Lehmann has prioritized completing the transaction before the end of 2026, a move considered essential for restoring capital market confidence.

Financing banks have granted the company vital breathing room. Holders of approximately 96% of the company's €870 million in Schuldschein loans agreed in mid-April to extend the deadline for submitting its audited 2025 annual report to September 30. Key financial covenants related to leverage ratios are also suspended until the end of the third quarter. This agreement, negotiated by interim CEO Uwe Röhrhoff, staves off an immediate liquidity crisis by preventing loan defaults but does not resolve underlying concerns about financial reporting.

Those concerns are the subject of an ongoing probe by German financial watchdog BaFin. The regulator is examining so-called "bill-and-hold" transactions, suspecting revenue may have been recognized prematurely in the company's books. The lack of an audited report also triggered Gerresheimer's removal from the SDAX index on April 10, forcing index-tracking funds to sell their holdings and exacerbating downward pressure on the share price.

A brief relief rally pushed the stock above €21.80 following the debt deal, but momentum quickly faded. Analysts stress that true transparency will only return with the publication of certified financial statements, which the company plans for June 2026. Until then, market sentiment hinges almost entirely on progress with the Centor sale and the company's cooperation with BaFin's investigation. With short sellers likely to dominate trading until the September deadline, the recent low of €15.57 could soon return to focus if the current weakness persists.

Ad

Fresh Gerresheimer information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.